Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01503164 · ClinicalTrials.gov registry record · NA
Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
NCT01503164: Completed NA study, sponsored by Johns Hopkins University.
NCT01503164 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01503164, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
Study Summary
Obstructive sleep apnea affects approximately 2-4% of middle-aged adults in the general population and is associated with several medical conditions including hypertension and coronary artery. Research over the last decade has shown that obstructive sleep apnea may also increase the propensity for insulin resistance, glucose intolerance, and type 2 diabetes mellitus. Positive airway pressure (PAP) is the first line therapy for the treatment of obstructive sleep apnea. While PAP therapy has several favorable effects such as improvements in daytime sleepiness and quality of life, it is not clear whether using PAP therapy can alter metabolic risk. The overall objective of this study is to examine whether treatment of obstructive sleep apnea with positive airway pressure therapy improves glucose tolerance and insulin sensitivity. The primary hypothesis of this study is that PAP therapy of obstructive sleep apnea will improve in insulin sensitivity and glucose metabolism.
Interventions
- BEHAVIORAL LifeStyle Counseling
- DEVICE Positive Pressure Therapy (PAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01503164
The ClinicalTrials.gov registry entry for NCT01503164 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LifeStyle Counseling is the first listed.
NCT01503164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01503164 about?
NCT01503164 is a clinical study titled "Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism". Obstructive sleep apnea affects approximately 2-4% of middle-aged adults in the general population and is associated with several medical conditions including hypertension and coronary artery. Research over the last decade has shown that obstructive sleep apnea may also increase the propensity for i...
What is the current status of trial NCT01503164?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2011-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01503164?
The interventions under investigation include: LifeStyle Counseling (BEHAVIORAL), Positive Pressure Therapy (PAP) (DEVICE).
Who is sponsoring clinical trial NCT01503164?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.